BioNeutral Group Hosts Discussions with Four of the World’s Largest Health Care Companies All Interested in Ygiene™ Sporicidal Antimicrobial Performance on Skin and Surfaces
NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world’s largest health care companies. The discussions included both scientific and business representatives all interested in BioNeutral's game changing technology - "Sporicidal performance on surfaces and skin.” Game changing technology is an infrequent occurrence. However, it is easy to identify and differentiate from the run of the mill or obsolete technology and thus generates intense interest. BioNeutral is in a unique position in that it has not solicited contacts with major players in the antimicrobial and health care arena; instead these well known companies have been contacting BioNeutral to develop partnering relationships...................... continued on link provided
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
.79 now. Will we hit $1.00 today? I lowered my sell order from $1.29 to .73 this morning - but just raised it back up to $1.30 for now!
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
BioNeutral Group Hosts Discussions with Four of the World's Largest Health Care CompaniesFont size: A | A | A8:30 AM ET 8/24/09 | BusinessWire BioNeutral Group, Inc. ("BioNeutral") (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world's largest health care companies. The discussions included both scientific and business representatives all interested in BioNeutral's game changing technology - "Sporicidal performance on surfaces and skin." Game changing technology is an infrequent occurrence. However, it is easy to identify and differentiate from the run of the mill or obsolete technology and thus generates intense interest. BioNeutral is in a unique position in that it has not solicited contacts with major players in the antimicrobial and health care arena; instead these well known companies have been contacting BioNeutral to develop partnering relationships.
Any antimicrobial which is not sporicidal may be a carrier for the dangerous and difficult to kill organisms which may then be transported from person to person (this includes all known alcohol, silver or quat based formulations). For example, Clostridium Difficile spores are associated with hospital acquired infections which results in diverted heath care provider's efforts, millions of dollars in extra expenses and hundreds of thousands of unnecessary deaths annually in the US alone. The best high powered currently used hospital disinfectants based upon quaternary ammonium compounds, silver based disinfectants or alcohol washes are totally ineffective at eradicating Clostridium Difficile (C-diff) spores, resulting in a serious unmet need in the health care arena. BioNeutral's Ygiene(TM) is the clear solution for this serious problem.
Dr. Andy Kielbania, Chief Scientist at BioNeutral Group stated, "Results of in-house testing conducted this past week demonstrated a 30 second kill time for the most difficult to kill spores with a mild formulation that is gentle to skin, surfaces and fabric. These are the best results we have produced thus far."
"When these results are confirmed by independent testing," said one of the health care executives, "It represents a game changer which will determine control of a worldwide antimicrobial health care market."
BioNeutral Group Inc. CEO, Stephen J. Browand, stated, "If game changing technology were presently out there, we would not be inundated with calls from the major players in the healthcare field. Killing low level microorganisms with old, me too technology (alcohol, silver, quats or bleach) has been available for quite some time. Rapidily eliminating dangerous spores such as Clostridium Difficile (C-diff) with our new mild Ygiene(TM) formulation which can be exposed to skin is considered the holy grail of antimicrobial performance. Independent lab testing confirming last week's R&D breakthrough should take approximately three weeks".
BioNeutral Group Inc. has confirmed independent test results which indisputably show the Company's Ygiene(TM) formulations outperform virtually all antimicrobials available when it comes to difficult to kill, dangerous organisms including black mold. Dissimilar to silver, bleach and quat based older technology; BioNeutral's Ygiene(TM) is non corrosive, non-staining, non flammable and completely sporicidal.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and Chemo Neutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
SOURCE: BioNeutral Group, Inc.
BioNeutral Group Inc. Stephen J. Browand, President and CEO steve*bioneutralgroup.com or Investor Relations Aimee Boutcher, 973 239-2878 aboutcher*aol.com
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
Today it started and flew to 0.79, then decended to 0.72. We may see another great run before noon or after. I think it's trying to collect more steam after yesterday's activities.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
BioNeutral Group, Inc. Hires The Investor Relations Group BioNeutral Group, Inc. Hires The Investor Relations Group Aug. 26, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU - News), a specialty chemical technology based life science company, has hired the Investor Relations Group (“IRG”), a thirteen-year-old corporate communications firm based in New York City, to serve as its investor relations and public relations agency.
IRG’s investor relations team will implement competitive analysis strategies and its proprietary database of portfolio managers and equity analysts in the global investment community to increase awareness of BioNeutral’s status as an innovator in the antimicrobial industry. The program will include pre-qualified one-on-one introductions, traditional outreach practices, and strategic advisement. Concurrent with that effort, the public relations team will initiate an outreach campaign targeting editors, writers, and segment producers of local and national trade and consumer online, print, radio, and broadcast media outlets.
IRG’s corporate communications program includes new media and multimedia initiatives that involve the creation of broadcast-ready corporate videos, podcasts, and the creation of social networking, video service, and micro-****ging accounts. The Investor Relations Group was recently honored with a “Stevie Award” for Investor Relations Program of the Year and named a finalist in the Best Media Website category from the 2009 American Business Awards.
“BioNeutral is nearing the registration of our lead Ygiene™ product technology with the EPA,” said Stephen J. Browand, the company’s President and Chief Executive Officer. “This is a very significant milestone in the company’s history and we feel that IRG has the expertise and industry relationships necessary to help us meet our objectives, gain exposure, and ultimately raise our corporate profile. BioNeutral is a unique company with products that have many technical advantages over existing, better-known items currently on the market. We have every confidence in IRG’s ability to successfully communicate our story with the investment community, our shareholders, the media, and the public-at-large.”
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
BioNeutral's Ygiene(TM) Kills Dangerous MRSA in Seconds BioNeutral's Ygiene(TM) Kills Dangerous MRSA in Seconds Aug. 27, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.
MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.
“These independent ATS Labs test results completely validate our internal product development efforts,” said BioNeutral Chief Scientist for BioNeutral, Dr. Andrew Kielbania. “The level of efficacy demonstrated in these independent tests is exceptional. Passing this difficult EPA required test for the elimination of MRSA is consistent with the ability of our Ygiene™ Hospital Grade Antimicrobial to address a very serious unmet need associated with Hospital Acquired Infections in the health care area. We believe our Ygiene™ Hospital Grade Antimicrobial will contribute to the saving of many lives in addition to resources at health care facilities.”
“We often use independent labs to support our in-house work, and are very pleased with these test results,” said Stephen Browand, CEO at BioNeutral. “We use tests that demand exceptional performance from our antimicrobial products. Current disinfectants on the market are clearly not doing the job when it comes to controlling HAIs; we believe that our antimicrobial products will help remedy that unacceptable situation. Given these impressive results, we have every confidence that our Ygiene Hospital Grade Antimicrobial will have a major impact in reducing Hospital Acquired Infections and saving lives while protecting the environment.”
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
Yes we will and I'll get out around then and buy back after expected shades..
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
I got out at $1.04. When it shades some, I'll buy back. I was a very fun ride, although the ride is not over yet.....
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
Love the market , did you get out or stayed ? The peak for today's run was at $1.18. What a ride !! For those of you who also made money, congratulations !!!
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
quote:Originally posted by Hot-Pepper: How I wish I did not get out. It's now at $1.45.
I feel the same way...but I'm not gonna complain about profits. I've been caught holding on to some for to long before.
Posts: 7 | Registered: Sep 2008
| IP: Logged |
posted
I've been in and out of this one - staying in until after H1N1 (swine) flu runs its course in the fall. 100% kill rate for the virus - still a lot of room to move imo.
-------------------- Taking care of my own money because no one else will treat it like their own! Posts: 14 | From: Good old US of A | Registered: Aug 2009
| IP: Logged |
posted
Skymark Research Initiates Independent Research Coverage On BioNeutral Group, Inc. Friday 08/28/2009 9:47 AM ET - Globenewswire
Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on BioNeutral Group, Inc. (OTCBB:BONU). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com
About SMR:
Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php
About BioNeutral Group, Inc. (OTCBB:BONU):
BioNeutral Group, Inc. (OTCBB:BONU) is headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey. BioNeutral Group, Inc. is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(tm) and Ogiene(tm), which are eco-friendly and include natural and common ingredients which are found in baby products and in everyday foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
SMR Disclosure:
Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures.
CONTACT: Skymark Research Dylan Boyle 202-657-6249 info*skymarkresearch.com
-------------------- Taking care of my own money because no one else will treat it like their own! Posts: 14 | From: Good old US of A | Registered: Aug 2009
| IP: Logged |
posted
Hot-Pepper: Every time I look at the pps, I feel like I've eaten Green Chilli from New Mexico - laced with pure black peppercorns!!
I was taken out Thursday for 4200 at $1.03 and actually got $1.04 for 800 shares on a $1.03 limit order - so it must have been FLYING. I said $1.03 by lunch on the "Hot Stocks" thread, and I was taken out at 11am!
I made $3,150 on it and was only in less than a week at .43 - Funny (but NOT) I had a buy in Thursday for another 2500 at .70 and CANCELED it at about 3pm to try and buy something else. Didn't get it - BUT BONU dropped to .68 before closing at .73 - so I would have made another $625 and ALMOST woould be recovered from by Eddie Bauer and BHWF losses. Imagine that - I've had 2 doubles and a double 'n a half-er, and I'm still down big over the years - but I've made more in the past 2 months than the past 6 years!
I wish I didn't change my sell down from $1.29 the other day - I put a new order in to buy 8000 at .80 - but it may not drop that low for a bit -This COULD be a $10 stock THIS year, imho. But who knows.....
At $1.50.... I would have almost made up for MANY MANY losses!
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Should we all buy back in at $2.00 Monday??? LOL Crap - watch it happen! Hey - we just need to find another one!
UNBELIEVEABLE. I also just saw on FOX's "Fast Money" after the Space Shuttle safely launched - that Fannie and Freddie are over $2.30?? Where the F_ck were WE? I dropped them off my watch list about a month ago -because I thought (I DIDN'T think it out is the problem)because at .80 to $1.10 it was too CRAZY! (I didn't buy them at .34 either)! Don't even get me started on C at $1.00 and BAC at $4.00- ...EWWWWwwwwwwww.
Enjoy your weekend! Steve
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
New York Times article about BONU. Now the company info is out to investors who don't necessarily follow penny stocks. I'm still predicting up through late fall.
From Saturday's New York Times Business News: BioNeutral Group Inc. BONU: OTC Bulletin Board Market; Healthcare/Biotechnology
Company Information BioNeutral Group, Inc., formerly Moonshine Creations, Inc., is a specialty life science company. The Company is focused on commercializing a combinational chemistry-based technology, which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms, including bacteria, viruses and even spores. The formulations, including Ygiene and Ogiene, include natural and common ingredients, which are found in baby products and in every day foods. In March 2009, the Company announced that it formed a wholly owned subsidiary, Advanced Bio-Fiber Treatments Corp., which is focused on utilizing its chemical technology to treat fibers and textiles with anti-chemical and antimicrobial properties. BioNeutral Group Inc. 211 Warren Street Newark NJ 07103 Phone: +1 (973) 286-2899
-------------------- Taking care of my own money because no one else will treat it like their own! Posts: 14 | From: Good old US of A | Registered: Aug 2009
| IP: Logged |
-------------------- Taking care of my own money because no one else will treat it like their own! Posts: 14 | From: Good old US of A | Registered: Aug 2009
| IP: Logged |
posted
Resistance?? I don't think BONU HAS any resistance!?!?!?! Congrats to all of you with big ones who stayed in or got back in Friday!
(I just have to be a happy little pig on this one - but the "What COULD of been and ALMOST was is driving me NUTS....WOuld have wiped out all my losses over the past 6 years)! HAHA
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
I just want to add just a little caution. This stock has been great to me, but they actually are being pumped to the max. If you look at the product "Lysol" you will see that it kills all the germs bonu's product does. H1N1 is not some hard to kill virus, it is the flu virus and can be killed on contact by many products already on the market. They are carrying on like this is the Andromeda strain. This concerns me as they have yet found a market for their product. Not to burst any bubbles, just be careful.
posted
I got in again at $2.18 in the morning. but after I came back from a late lunch with my son in the afternoon, the stock was at $2.45.
This stock is destined to $5.00 before the week is over in my own opinion and may even reach a higher destination than that...again this is in my poor insight opinion. If not, oh well it would be just like other disappointing ones I have wtched over the years. But just be careful and do your own research before purchasing and be cautious!!. Company products and services although similar in some cases are different and are for different purposes and uses.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
I do agree with Dagny... I think ppl are misreading into the product as I stated on the Hot Stocks forum. If this thing still keeps flying who cares...
But Dagny if you look at the Investor packet from the website I guess it's a "green" product that doesn't cause any corrosion. I haven't done any research on lysol or competitors on how fast and how green they work...
Bioneutral finally just now reached out to me after almost two weeks... If I can get any answers that are relavent I'll post em.
Just a heads up to all. Looking on Ihub someone posted that ***** is now on this stock. I havn't looked at his site to verify but I'd begin to watch this carefully in my personal opinion ... Then again I didn't think she'd run like she has In the end it's your money and who really knows just how far this puppy will go...
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
All of a sudden - I hate being a happy little pig on this one - from the $3K I made last week, but the "What COULD of been and ALMOST was" - like up $15K; is driving me NUTS....Would have wiped out all my losses over the past 6 years and even put me positive a little.... Hey - could have also gone the other way like so many others do.
CONGRATS and Good Luck to all still in!
Steve
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Bonu is taking a dip dip, time to get in or watch to see what it's going to do
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
I got out at 2.80. I am waiting to get in again. I do not know why it took such a drastic dive. I guess profit takers.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
I think it's resting a little today, except that it's down, but still talking loud. imo. When it gets up, we hope to see it fly again. thanks to profit takers.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
BONU Trade News 1.635 0.125 BioNeutral Has Retained DC-Based Law Firm Hogan & Hartson to Manage Its EPA/FDA Regulatory Process
Sep 3, 2009 08:57:00 (ET)
NEWARK, N.J., Sep 03, 2009 (BUSINESS WIRE) -- BioNeutral Group, Inc. (BONU, Trade ) has retained Hogan and Hartson, one of Washington's oldest and most prestigious law firms, to manage its regulatory affairs as it proceeds through the approval process for its technology. Patrick Raher, a senior partner and the chairman of Hogan & Hartson's environmental practice, will serve as lead counsel for the BioNeutral Group.
BioNeutral is a publicly traded specialty life science company that is developing several product lines intended to neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. Some of its product applications (hard and soft surface sterilants and disinfectancts) will require certification by the Environmental Protection Agency (EPA); others (wound care, acne, sterilization of medical/surgical/dental instruments) will require approval by the Food and Drug Administration (FDA). Other product applications in the pipeline, such as stain removers, cleaners, and rust inhibitors are not regulated. Hogan & Hartson has decades of experience in helping clients achieve efficient certification and approvals in the Federal and state regulatory process.
With more than 1,100 lawyers practicing in 27 offices worldwide, Hogan & Hartson brings multiple practices and offices to bear to provide its clients with exceptional service and creative advice. Working at the intersection of business and government, both domestically and internationally, the firm helps its clients structure and complete their projects and transactions and guides them through the maze of government regulation. The firm also has special expertise in securing, protecting, and defending their clients' intellectual property.
"I have great confidence in Mr. Raher's and his team's professional ability," said Dr. Jeffrey Runge of Washington's Chertoff Group and BioNeutral's senior medical advisor. "As the former head of the National Highway Traffic Safety Administration, I had the opportunity to witness his firm's ability from the perspective of a Federal regulator. They have the highest integrity and clearly understand the regulatory process."
"We are extremely pleased to have this highly experienced and prestigious law firm join our group of platinum advisors to assist us in navigating the complexities of the regulatory process. This move will consolidate our various product registrations and is a key component to our overall business strategy," stated Stephen J. Browand, President & CEO of BioNeutral.
ABOUT BIONEUTRAL GROUP
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene and Ogiene, which are eco-friendly and include natural and common ingredients found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers.
BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene and are not yet available for sale in the United States.
Under the Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes", and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of BioNeutral Group can be found in the filings of BioNeutral Group with the U.S. Securities and Exchange Commission.
SOURCE: BioNeutral Group, Inc.
The Investor Relations Group Erika Moran/Tom Caden, 212-825-3210 or Public Relations: Laura Colontrelle, 212-825-3210
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
Bonu is on it's way to recovery after a very hard fall yesterday and before.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
Previous closed at $1.51 Opened at $1.415 Day's Low $1.41 Day's high $2.05 Closed at $1.80 Change $0.29 (19.21%) Asking Price $1.84
Let's see if it will increase the pace more tomorrow. Maybe I'll recover from this one.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Big Grin]](biggrin.gif)
In the end it's your money ![[Wink]](wink.gif)
and who really knows just how far this puppy will go...
